MolnupiravirLack of efficacy and off-label use

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57639-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：546 / 546

相关论文

共 50 条

[21] Lopinavir/ritonavirLack of efficacy and off-label use
Reactions Weekly, 2024, 2003 (1) : 518 - 518
[22] Dexamethasone/favipiravirLack of efficacy and off-label use
Reactions Weekly, 2024, 2006 (1) : 231 - 231
[23] TemozolomideLack of efficacy following off-label use
Reactions Weekly, 2024, 2002 (1) : 433 - 433
[24] PrednisoneLack of efficacy following off-label use
Reactions Weekly, 2024, 2005 (1) : 704 - 704
[25] Lenvatinib/pembrolizumabLack of efficacy and off-label use
Reactions Weekly, 2023, 1977 (1) : 174 - 174
[26] Multiple drugsLack of efficacy and off-label use
Reactions Weekly, 2024, 2007 (1) : 253 - 253
[27] Multiple drugsLack of efficacy and off-label use
Reactions Weekly, 2024, 1991 (1) : 157 - 157
[28] Dexamethasone/remdesivirLack of efficacy and off-label use
Reactions Weekly, 2024, 2005 (1) : 315 - 315
[29] DexamethasoneLack of efficacy following off-label use
Reactions Weekly, 2024, 2005 (1) : 303 - 303
[30] Multiple drugsLack of efficacy and off-label use
Reactions Weekly, 2024, 2016 (1) : 340 - 340

← 1 2 3 4 5 →